西地那非在胆管结扎大鼠模型中减弱胆汁淤积相关的胆汁淤积性肾病。

IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY
Clinical and Experimental Hepatology Pub Date : 2025-06-01 Epub Date: 2025-06-27 DOI:10.5114/ceh.2025.151865
Heresh Rezaei, Akram Jamshidzadeh, Hossein Niknahad, Fatemeh Ghaderi, Omid Farshad, Forouzan Khodaei, Tahereh Golzar, Zahra Honarpishefard, Nazi Dastkhosh, Sepideh Maghami, Kiana Yousefipour, Negar Azarpira, Reza Heidari
{"title":"西地那非在胆管结扎大鼠模型中减弱胆汁淤积相关的胆汁淤积性肾病。","authors":"Heresh Rezaei, Akram Jamshidzadeh, Hossein Niknahad, Fatemeh Ghaderi, Omid Farshad, Forouzan Khodaei, Tahereh Golzar, Zahra Honarpishefard, Nazi Dastkhosh, Sepideh Maghami, Kiana Yousefipour, Negar Azarpira, Reza Heidari","doi":"10.5114/ceh.2025.151865","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim of the study: </strong>Cholestasis is characterized by impaired bile flow from the liver to the small intestine. Beyond liver damage, cholestasis significantly affects other organs, particularly the kidneys, causing a condition known as cholemic nephropathy (CN). Sildenafil is a phosphodiesterase type 5 (PDE5) enzyme inhibitor with a wide range of pharmacological effects. Several studies have described the nephroprotective properties of sildenafil.</p><p><strong>Material and methods: </strong>Rats underwent bile duct ligation (BDL) surgery to induce cholestasis and CN. Afterward, BDL animals received sildenafil (5, 10, and 20 mg/kg/day, i.p., for 14 consecutive days). Urine, blood, and kidney samples were collected for further evaluation.</p><p><strong>Results: </strong>Elevated levels of blood urea nitrogen (BUN) and creatinine (Cr) and urinalysis revealed renal injury in this model (<i>p</i> < 0.001). Oxidative stress markers, including depleted antioxidant capacity, increased ROS formation, lipid peroxidation, and protein carbonylation, were evident in the kidneys of BDL rats (<i>p</i> < 0.001). Moreover, the activity of enzymatic antioxidant systems (CAT, SOD, GR, and GPx) was also significantly decreased in the kidney of BDL animals (<i>p</i> < 0.001). Tissue pro-inflammatory cytokines (TNF-a, IL-6, and IL-1b) were also considerably higher in the kidney of cholestatic rats (<i>p</i> < 0.001). Renal histopathological changes in BDL animals included inflammatory cell infiltration, tubular atrophy, necrosis, significant fibrotic changes, and cast formation. It was found that sildenafil significantly reduced pathological changes, mitigated oxidative stress biomarkers, and suppressed inflammation in the kidneys of BDL animals. The nephroprotective effects of sildenafil were not dose-dependent in the current study.</p><p><strong>Conclusions: </strong>The data obtained from this study revealed that sildenafil could significantly protect against renal damage in cholestasis. The effect of sildenafil on oxidative stress and the inflammatory response plays an essential role in its nephroprotective mechanisms.</p>","PeriodicalId":10281,"journal":{"name":"Clinical and Experimental Hepatology","volume":"11 2","pages":"190-203"},"PeriodicalIF":1.7000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12403720/pdf/","citationCount":"0","resultStr":"{\"title\":\"Sildenafil blunts cholestasis-associated cholemic nephropathy in a rat model of bile duct ligation.\",\"authors\":\"Heresh Rezaei, Akram Jamshidzadeh, Hossein Niknahad, Fatemeh Ghaderi, Omid Farshad, Forouzan Khodaei, Tahereh Golzar, Zahra Honarpishefard, Nazi Dastkhosh, Sepideh Maghami, Kiana Yousefipour, Negar Azarpira, Reza Heidari\",\"doi\":\"10.5114/ceh.2025.151865\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim of the study: </strong>Cholestasis is characterized by impaired bile flow from the liver to the small intestine. Beyond liver damage, cholestasis significantly affects other organs, particularly the kidneys, causing a condition known as cholemic nephropathy (CN). Sildenafil is a phosphodiesterase type 5 (PDE5) enzyme inhibitor with a wide range of pharmacological effects. Several studies have described the nephroprotective properties of sildenafil.</p><p><strong>Material and methods: </strong>Rats underwent bile duct ligation (BDL) surgery to induce cholestasis and CN. Afterward, BDL animals received sildenafil (5, 10, and 20 mg/kg/day, i.p., for 14 consecutive days). Urine, blood, and kidney samples were collected for further evaluation.</p><p><strong>Results: </strong>Elevated levels of blood urea nitrogen (BUN) and creatinine (Cr) and urinalysis revealed renal injury in this model (<i>p</i> < 0.001). Oxidative stress markers, including depleted antioxidant capacity, increased ROS formation, lipid peroxidation, and protein carbonylation, were evident in the kidneys of BDL rats (<i>p</i> < 0.001). Moreover, the activity of enzymatic antioxidant systems (CAT, SOD, GR, and GPx) was also significantly decreased in the kidney of BDL animals (<i>p</i> < 0.001). Tissue pro-inflammatory cytokines (TNF-a, IL-6, and IL-1b) were also considerably higher in the kidney of cholestatic rats (<i>p</i> < 0.001). Renal histopathological changes in BDL animals included inflammatory cell infiltration, tubular atrophy, necrosis, significant fibrotic changes, and cast formation. It was found that sildenafil significantly reduced pathological changes, mitigated oxidative stress biomarkers, and suppressed inflammation in the kidneys of BDL animals. The nephroprotective effects of sildenafil were not dose-dependent in the current study.</p><p><strong>Conclusions: </strong>The data obtained from this study revealed that sildenafil could significantly protect against renal damage in cholestasis. The effect of sildenafil on oxidative stress and the inflammatory response plays an essential role in its nephroprotective mechanisms.</p>\",\"PeriodicalId\":10281,\"journal\":{\"name\":\"Clinical and Experimental Hepatology\",\"volume\":\"11 2\",\"pages\":\"190-203\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12403720/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/ceh.2025.151865\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ceh.2025.151865","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

研究目的:胆汁淤积症的特点是从肝脏到小肠的胆汁流动受损。除肝损害外,胆汁淤积还会显著影响其他器官,尤其是肾脏,导致一种称为胆汁淤积性肾病(CN)的疾病。西地那非是一种磷酸二酯酶5型(PDE5)酶抑制剂,具有广泛的药理作用。一些研究已经描述了西地那非的肾保护特性。材料和方法:采用胆管结扎术诱导大鼠胆汁淤积和胆管炎。随后,BDL动物接受西地那非(5、10和20 mg/kg/天,i.p,连续14天)。收集尿液、血液和肾脏样本作进一步评估。结果:大鼠血尿素氮(BUN)、肌酐(Cr)及尿分析显示肾损伤(p < 0.001)。氧化应激标志物,包括抗氧化能力下降、ROS形成增加、脂质过氧化和蛋白质羰基化,在BDL大鼠肾脏中是明显的(p < 0.001)。此外,BDL动物肾脏中酶抗氧化系统(CAT、SOD、GR和GPx)的活性也显著降低(p < 0.001)。组织促炎因子(TNF-a、IL-6和IL-1b)在胆汁淤积大鼠肾脏中也显著升高(p < 0.001)。BDL动物的肾脏组织病理学改变包括炎症细胞浸润、肾小管萎缩、坏死、明显的纤维化改变和铸型形成。研究发现,西地那非可显著降低BDL动物肾脏的病理变化,减轻氧化应激生物标志物,并抑制炎症。在目前的研究中,西地那非的肾保护作用不具有剂量依赖性。结论:本研究数据显示,西地那非对胆汁淤积的肾脏损害具有显著的保护作用。西地那非对氧化应激和炎症反应的影响在其肾保护机制中起重要作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Sildenafil blunts cholestasis-associated cholemic nephropathy in a rat model of bile duct ligation.

Sildenafil blunts cholestasis-associated cholemic nephropathy in a rat model of bile duct ligation.

Sildenafil blunts cholestasis-associated cholemic nephropathy in a rat model of bile duct ligation.

Sildenafil blunts cholestasis-associated cholemic nephropathy in a rat model of bile duct ligation.

Aim of the study: Cholestasis is characterized by impaired bile flow from the liver to the small intestine. Beyond liver damage, cholestasis significantly affects other organs, particularly the kidneys, causing a condition known as cholemic nephropathy (CN). Sildenafil is a phosphodiesterase type 5 (PDE5) enzyme inhibitor with a wide range of pharmacological effects. Several studies have described the nephroprotective properties of sildenafil.

Material and methods: Rats underwent bile duct ligation (BDL) surgery to induce cholestasis and CN. Afterward, BDL animals received sildenafil (5, 10, and 20 mg/kg/day, i.p., for 14 consecutive days). Urine, blood, and kidney samples were collected for further evaluation.

Results: Elevated levels of blood urea nitrogen (BUN) and creatinine (Cr) and urinalysis revealed renal injury in this model (p < 0.001). Oxidative stress markers, including depleted antioxidant capacity, increased ROS formation, lipid peroxidation, and protein carbonylation, were evident in the kidneys of BDL rats (p < 0.001). Moreover, the activity of enzymatic antioxidant systems (CAT, SOD, GR, and GPx) was also significantly decreased in the kidney of BDL animals (p < 0.001). Tissue pro-inflammatory cytokines (TNF-a, IL-6, and IL-1b) were also considerably higher in the kidney of cholestatic rats (p < 0.001). Renal histopathological changes in BDL animals included inflammatory cell infiltration, tubular atrophy, necrosis, significant fibrotic changes, and cast formation. It was found that sildenafil significantly reduced pathological changes, mitigated oxidative stress biomarkers, and suppressed inflammation in the kidneys of BDL animals. The nephroprotective effects of sildenafil were not dose-dependent in the current study.

Conclusions: The data obtained from this study revealed that sildenafil could significantly protect against renal damage in cholestasis. The effect of sildenafil on oxidative stress and the inflammatory response plays an essential role in its nephroprotective mechanisms.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical and Experimental Hepatology
Clinical and Experimental Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
2.80
自引率
0.00%
发文量
32
期刊介绍: Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信